Effect of Biologics on Cardiovascular Inflammation: Mechanistic Insights and Risk Reduction
George E Fragoulis,1,* Stergios Soulaidopoulos,2,* Petros P Sfikakis,1 Theodoros Dimitroulas,3 George D Kitas4,5 1Rheumatology Unit, Joint Rheumatology Program, Medical School, First Department of Propaedeutic Internal Medicine, National and Kapodistrian University of Athens, “Laiko&rd...
Guardado en:
Autores principales: | Fragoulis GE, Soulaidopoulos S, Sfikakis PP, Dimitroulas T, Kitas GD |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/e30d95732ee6484c85c6ccf84dda69b6 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Is there a link between inflammation and fatigue in multiple sclerosis?
por: Chalah MA, et al.
Publicado: (2018) -
Association of Inflammatory Markers/Cytokines with Cardiovascular Risk Manifestation in Patients with Endometriosis
por: Uzma Rafi, et al.
Publicado: (2021) -
Modulation of Chronic Inflammation by Quercetin: The Beneficial Effects on Obesity
por: Sato S, et al.
Publicado: (2020) -
Cooling and Sterile Inflammation in an Oxygen-Glucose-Deprivation/Reperfusion Injury Model in BV-2 Microglia
por: Jana Lücht, et al.
Publicado: (2021) -
The Regulation Effect of α7nAChRs and M1AChRs on Inflammation and Immunity in Sepsis
por: Song Hu, et al.
Publicado: (2021)